Skip to main content

Jean-Emmanuel Sarry

Submitted by com_inem on

Jean-Emmanuel Sarry is a Team Leader at the Cancer Research Center of Toulouse (France) and a Principal Investigator in Hemato-Oncology and Metabolism at the French Health Institute (Inserm). Dr. Sarry received his PhD degree in Biochemistry from the University of Montpellier.  He also completed his postdoctoral training in Plant and Yeast Metabolism at the Department of Plant Physiology (CEA, Grenoble, France) and the Department of Biology (University of Pennsylvania, Philadelphia).

INEM Scientific Photo Contest – 2025 Edition

Submitted by com_inem on

We are thrilled to announce the winners of the 2nd INEM Scientific Photo Contest, which once again highlighted the creativity and scientific diversity of our institute. From cellular landscapes to experimental snapshots, this year’s submissions showcased the fascinating beauty of science.

Jury’s Choice Awards

1st Prize – Mathieu Deygas — Neutro In Vitraux
2nd Prize – Tahina Randresy — First-ever Stem Cells Capable of Growing Forests
3rd Prize – Ana Raquel Cruz — Brief Encounters

Public Vote Winners

Khaled Tighanimine receives the Fondation ARC Oberling-Haguenau Thesis Prize

Submitted by admin_inem on

We are proud to share that Khaled Tighanimine, former PhD student at INEM under the supervision of Mario Pende and Stefano Fumagalli, has been awarded a Fondation ARC Oberling-Haguenau Thesis Prize during the 2025 Trophées de la Recherche ceremony.

This award highlights Khaled's remarkable doctoral work in the field of cancer research, carried out at INEM.

Our congratulations to Khaled and to all the laureates of this edition!

Elvira Mass

Submitted by com_inem on

Elvira Mass studied biology at the University of Bonn and did her PhD thesis at the Life and Medical Sciences Institute (LIMES) in Bonn. In 2014, she moved to Frederic Geissmann's laboratory at King's College in London and followed him a few months later to the Memorial Sloan-Kettering Cancer Center in New York. From there she returned to the LIMES Institute in Bonn in 2017 as a group leader. In 2019, she became Associate Professor for "Integrated Immunology" at the University of Erlangen-Nürnberg.

Bing Su

Submitted by com_inem on

Bing Su is Director of the Shanghai Institute of Immunology and Chair of the Department of Immunology and Microbiology at Shanghai JiaoTong University School of Medicine, where he also holds a KC Wong Chair Professorship. He co-founded the SJTU-Yale Institute for Immune Metabolism and is an Adjunct Professor in the Department of Immunobiology at Yale University.

Juliane Da Graça awarded the 2025 Thesis Prize of the Club Exo-Endo

Submitted by com_inem on

We are proud to announce that Juliane Da Graça, former PhD student at INEM, has been awarded the 2025 Thesis Prize of the Club Exocytose-Endocytose (Club Exo-Endo).

Juliane carried out her doctoral research in the MEMBRAMICS Lab, under the supervision of Etienne Morel. Her work focused on the role of contact sites between the endoplasmic reticulum and endosomes in the regulation of autophagy, both in physiological and cancer contexts.

Christopher Carl Goodnow

Submitted by com_inem on

Christopher C Goodnow holds The Bill and Patricia Ritchie Foundation Chair as Head of the Immunogenomics Laboratory at the Garvan Institute of Medical Research, and is Professor in the Cellular Genomics Futures Institute and School of Biomedical Sciences at UNSW Sydney. He trained in veterinary medicine and surgery, immunochemistry, and immunology at Sydney University and in DNA technology and molecular immunology at Stanford University.

New Publication in Nature Communications: Targeting metabolic vulnerabilities in PI3K-driven leukemia

Submitted by com_inem on

The PI3K (phosphoinositide 3-kinase) signaling pathway is a key driver of metabolic plasticity in aggressive tumors, enabling them to adapt to their microenvironment and resist treatment. However, effectively targeting these cancers remains a major challenge.

In their study published in Nature Communications, Guillaume P. Andrieu et al. propose a promising new therapeutic approach to target leukemias harboring PI3K pathway alterations, which are often associated with poor prognosis and aggressive disease.

Meryem Baghdadi named among the top 100 scientists in the 2025 Inventors' Ranking

Submitted by com_inem on

Congratulations to Meryem Baghdadi for being featured in Le Point’s 2025 Inventors' Ranking, which highlights 100 scientists whose research is making a difference. This recognition reflects her contributions and dedication to advancing fundamental science.

Kudos to all the laureates!

Subscribe to